Project Grant R01DK141617
- Federal Grant Award Summary The University of Virginia received a $788,831 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 1, 2026 through December 31, 2029. The award funds development of a ketone-aware automated insulin delivery (AID) system designed to enable safe use of sodium-glucose cotransporter inhibitors (SGLT1) in...
- Federal Project Grant Award Summary The University of Pittsburgh received a $1,325,413 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 25, 2025, with completion anticipated by January 31, 2029. This research project investigates novel aspects of Growth Differentiation Factor 15 (GDF15) biology to advance understanding of...
- Federal Grant Award Summary The University of Virginia received a $829,985 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded July 1, 2025, with completion targeted for April 30, 2030. This award supports the development and utilization of new Drosophila (fruit fly), mouse, and human podocyte models to investigate the molecular mechanisms by which...
- Federal Grant Award Summary The University of Virginia received a $732,261 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 15, 2025, with completion targeted for June 30, 2029. The award supports research leveraging large-scale multi-ethnic, multi-omic data to identify and validate causal genes associated with central obesity, which is a stronger predictor of cardiovascular...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Virginia $162,476 on June 3, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on renin cell identity and function. The project, titled "The Reninness Score: Integrative Analysis of Multi-Omic Data to Define Renin Cell Identity," will be completed by December 31, 2026. The research...
- Federal Project Grant Award Summary The University of Alabama at Birmingham (UAB) received a $2.38 million Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 7, 2025, with a completion date of August 31, 2029. The grant funds research investigating the role of histone H3 O-linked β-N-acetylglucosamine (O-GlcNAc) modification in...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $242,250 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective August 12, 2025, with completion scheduled for July 31, 2027. The award funds a research initiative titled "Understanding Diabetes and Peripheral Artery Disease-Related Amputation...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $843,485 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, obligated on September 5, 2025, with a completion date of August 31, 2030, funds a comprehensive research evaluation of novel, population-tailored health insurance designs and their...
- Federal Project Grant Award Summary The University of Massachusetts Medical School received a $2.64 million project grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through August 31, 2029. This research award funds an investigator-initiated project examining novel mitochondrial mechanisms in obesity pathogenesis, specifically...
- Federal Project Grant Award Summary Virginia Polytechnic Institute & State University (Virginia Tech) received a $1,380,079 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, effective March 1, 2025, through December 31, 2028, funds research investigating sub-second catecholamine dynamics underlying food reward in humans. The research addresses...
The University of Virginia received a $782,459 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective March 1, 2026 through February 28, 2031. This five-year research initiative investigates the mechanisms by which obesity exacerbates cardiovascular disease (CVD) risk in individuals with Type 1 Diabetes (T1D) by examining the relationship between microvascular insulin resistance, endothelial oxidative stress, and cardiorespiratory fitness. The research will establish whether skeletal and cardiac muscle microvascular insulin resistance predicts cardiorespiratory fitness reduction and whether obesity compounds these abnormalities in T1D populations. The project will deliver scientific evidence through three primary research aims: characterizing the predictive value of microvascular insulin resistance on cardiorespiratory fitness in T1D; evaluating the impact of obesity on microvascular insulin resistance and fitness decline; and testing whether 14 weeks of high-intensity intermittent exercise training can attenuate microvascular insulin resistance and improve cardiorespiratory fitness in individuals with T1D, obesity, or both conditions. The deliverables will include comprehensive analysis of interrelationships among microvascular insulin responses, endothelial cell oxidative stress, cardiac function, muscle function, and vascular function before and after exercise intervention, ultimately providing evidence to inform therapeutic interventions and CVD prevention strategies for this high-risk population.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $782.5k | 2/17/26 |